(1)
Serum Ferritin As a Prognostic Biomarker in CAR-T Therapy for Multiple Myeloma: A Meta-Analysis. Biomol Biomed 2025, 25 (11), 2416–2427. https://doi.org/10.17305/bb.2025.12129.